Literature DB >> 20476597

[Validity and reliability of the quality of life questionnaire (EORTC QLQ C30) and its breast cancer module (EORTC QLQ BR23)].

Katarzyna Zawisza1, Beata Tobiasz-Adamczyk, Wojciech Nowak, Jan Kulig, Joanna Jedrys.   

Abstract

OBJECTIVES: The aim of this study was to assess validity and reliability of the EORTC QLQ C30 and BR23 questionnaires among patients with breast neoplasm in Poland.
MATERIAL AND METHODS: Analysis was done on the basis of research conducted at the First Department of General Surgery JUMC, Kraków, among 105 women. Two aspects of questionnaire validity have been analyzed: construct validity using principal component analysis and criterion validity evaluated by comparison of two clinical subgroups of patients. Reliability analysis was done by estimating internal consistency using Cronbach's alpha coefficient and correlations between items and hypothesized scales. In addition, test-retest reliability was evaluated by calculating the correlation coefficient between two assessments, done 6 and 12 months after treatment.
RESULTS: All scales met Nunnally's criterion except for the scale of nausea and vomiting. Almost all variables met Kline's criterion, except for two variables: one from the scale of physical functioning and the other a part of the scale of systemic therapy side effects. High correlations obtained by the test-retest method confirmed the reliability of all scales. Analysis showed some fault in the theoretical validity of the scale of systemic therapy side effects. Nonetheless, criterion validity was confirmed for all scales.
CONCLUSIONS: Results have confirmed the validity and reliability of the EORTC QLQ C30 and BR23 tests as instruments for quality of life evaluation in Polish patients.

Entities:  

Mesh:

Year:  2010        PMID: 20476597

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  13 in total

Review 1.  Evaluation of cross-cultural adaptation and measurement properties of breast cancer-specific quality-of-life questionnaires: a systematic review.

Authors:  Indiara Soares Oliveira; Lucíola da Cunha Menezes Costa; Felipe Ribeiro Cabral Fagundes; Cristina Maria Nunes Cabral
Journal:  Qual Life Res       Date:  2014-11-13       Impact factor: 4.147

2.  Health status among long-term breast cancer survivors suffering from higher levels of fatigue: a cross-sectional study.

Authors:  Francisco Álvarez-Salvago; Noelia Galiano-Castillo; Manuel Arroyo-Morales; Mayra Cruz-Fernández; Mario Lozano-Lozano; Irene Cantarero-Villanueva
Journal:  Support Care Cancer       Date:  2018-05-05       Impact factor: 3.603

3.  Prevalence and risk factors associated with pain 21 months following surgery for breast cancer.

Authors:  Niamh Moloney; Jennie Man Wai Sung; Sharon Kilbreath; Elizabeth Dylke
Journal:  Support Care Cancer       Date:  2016-06-07       Impact factor: 3.603

4.  Development and Validation of the Breast Cancer Scale QLICP-BR V2.0 Based on Classical Test Theory and Generalizability Theory.

Authors:  Fei Li; Jiali Zhou; Chonghua Wan; Zheng Yang; Qilian Liang; Weiqiang Li; Huanwei Chen
Journal:  Front Oncol       Date:  2022-06-13       Impact factor: 5.738

Review 5.  Bringing Patient-Centered Care to the Fore in Diseases of the Pancreas.

Authors:  Sayali A Pendharkar; Maxim S Petrov
Journal:  Gastroenterol Res Pract       Date:  2015-05-14       Impact factor: 2.260

6.  Quality of Life of Women with Breast Cancer and Socio-Demographic Factors.

Authors:  Magdalena Konieczny; Elżbieta Cipora; Katarzyna Sygit; Andrzej Fal
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

7.  Comparing Quality of Life in Breast Cancer Patients Who Underwent Mastectomy Versus Breast-Conserving Surgery: A Meta-Analysis.

Authors:  Elvin T Ng; Russell Z Ang; Bach X Tran; Cyrus S Ho; Zhisong Zhang; Wanqiu Tan; Yu Bai; Min Zhang; Wilson W Tam; Roger C Ho
Journal:  Int J Environ Res Public Health       Date:  2019-12-06       Impact factor: 3.390

8.  Impact of Time to Initiation of Treatment on the Quality of Life of Women with Breast Cancer.

Authors:  Magdalena Konieczny; Elżbieta Cipora; Wojciech Roczniak; Magdalena Babuśka-Roczniak; Marek Wojtaszek
Journal:  Int J Environ Res Public Health       Date:  2020-11-11       Impact factor: 3.390

9.  Quality of life among chronic myeloid leukemia patients in the second-line treatment with nilotinib and influential factors.

Authors:  Cuc Thi Thu Nguyen; Binh Thanh Nguyen; Thuy Thi Thu Nguyen; Fabio Petrelli; Stefania Scuri; Iolanda Grappasonni
Journal:  Qual Life Res       Date:  2021-07-14       Impact factor: 4.147

10.  Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice.

Authors:  Krzysztof Adamowicz; Zuzanna Baczkowska-Waliszewska
Journal:  Health Qual Life Outcomes       Date:  2020-05-12       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.